Silexion Therapeutics Corp Quarterly Liabilities and Equity in USD from Q4 2023 to Q2 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: Silexion Therapeutics Corp quarterly Liabilities and Equity history and growth rate from Q4 2023 to Q2 2025.
Silexion Therapeutics Corp Liabilities and Equity for the quarter ending June 30, 2025 was $5.8M, a 130% increase year-over-year.

Liabilities and Equity, Quarterly (USD)

Liabilities and Equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2025	$5.8M	+$3.27M	+130%	Jun 30, 2025	10-Q	2025-08-12
Q1 2025	$8.31M			Mar 31, 2025	10-Q	2025-05-13
Q4 2024	$2.86M	-$2.39M	-45.5%	Dec 31, 2024	8-K	2025-08-20
Q3 2024	$3.09M			Sep 30, 2024	10-Q	2024-11-14
Q2 2024	$2.53M			Jun 30, 2024	10-Q	2024-08-29
Q4 2023	$5.26M			Dec 31, 2023	8-K	2025-08-20

* An asterisk sign (*) next to the value indicates that the value is likely invalid.